Therapies
Thursday, March 29th, 2012
Rehabilitation is crucial after a stroke. Yet patients don’t always do their exercises because they’re boring or difficult to do at home. Physorg.com: March 27, 2012. But what if you could make them easy and fun? Enter University of Toronto Associate Professor Alex Mihailidis and his intelligent, table-top robot. “This new robot will help to […]
Therapies
Thursday, March 29th, 2012
Stroke.ahajournals.org: Miriam Brazzelli, BSc, PhD; David H. Saunders, BSc, MPhil, PhD; Carolyn A. Greig, BSc, MSc, PhD; Gillian E. Mead, MB, BChir, FRCP, MD, MA, March 15, 2012. Physical fitness is low after stroke and this may cause or exacerbate some common poststroke problems, including disability. It is not known whether improving physical fitness or participating […]
Therapies
Thursday, March 29th, 2012
Stroke.ahajournals.org: Olga P. Madej-Fermo, MD; Ilene Staff, PhD; Gil Fortunato, MBA; Lincoln Abbott, MD; Louise D. McCullough, MD, PhD, March 26, 2012. Background and Purpose—In-hospital mortality is higher for certain medical conditions based on the time of presentation to the emergency department. The primary goal of this study was to determine whether patients with acute ischemic […]
Therapies
Thursday, March 29th, 2012
Stroke.ahajournals.org: Waleed Brinjikji, MD; Alejandro A. Rabinstein, MD; Harry J. Cloft, MD, PhD, March 22, 2012. Background and Purpose—It is important to know the costs for hospitalization for ischemic stroke patients treated with intravenous thrombolysis so that comparisons can be made with payments to hospitals. Methods—Using the National Inpatient Sample, we evaluated hospitalization costs for patients […]
Atrial Fibrillation
Thursday, March 29th, 2012
Cmio.net: March 29, 2012. CHICAGO—Calculating the cost-benefit ratio of remote monitoring patients who have implantable cardioverter-defibrillators (ICDs) depends on many variables, and the answer hinges on who pays and who benefits, said Mark H. Schoenfeld, MD, of Yale University School of Medicine in New Haven, Conn., in a March 24 presentation at the 61st annual […]
Atrial Fibrillation
Thursday, March 29th, 2012
American Heart Association: Joon Bum Kim1; Joon Suk Moon2; Sung-Cheol Yun2; Wan Kee Kim1; Sung-Ho Jung1; Suk Jung Choo1; Hyun Song3; Cheol Hyun Chung1; Jae Won Lee1*, March 28, 2012. Background—The long-term benefits of the Maze procedure in patients with chronic atrial fibrillation (AF) undergoing mechanical valve replacement who already require lifelong anticoagulation remain unclear. […]
Atrial Fibrillation
Thursday, March 29th, 2012
Cardiovascular Business: Written by Justine Cadet, March 27, 2012. CHICAGO—The usage of dabigatran, rivaroxban and apixaban may be associated with a reduction in medical costs when used instead of warfarin—with apixaban “potentially” being associated with the greatest cost reduction, based on an analysis of ARISTOTLE, RE-LY and ROCKET-AF trials, presented March 26 at the 61st annual American […]
Atrial Fibrillation
Thursday, March 29th, 2012
Emergence of Alternative Oral Anticoagulants Circ.ahajournals.org: Michael Katsnelson, MD; Ralph L. Sacco, MD, MS, FAHA, FAAN; Mauro Moscucci, MD, MBA., March 27, 2012. Atrial fibrillation (AF) is both a common cardiac arrhythmia and a frequent cause of cardioembolic strokes. The prevalence of AF markedly increases with age and with the current population trends, the number of […]
News
Thursday, March 22nd, 2012
Medicalxpress.com: Neuroscience: March 21, 2012. Investigators at the Stanford University School of Medicine have shown that removing a matched set of molecules that typically help to regulate the brain’s capacity for forming and eliminating connections between nerve cells could substantially aid recovery from stroke even days after the event. In experiments with mice, the scientists demonstrated that […]
News
Thursday, March 22nd, 2012
American Heart Association: March 15, 2012. Abstract Background and Purpose—Pretreatment infarct volume appears to predict clinical outcome after intra-arterial therapy. To confirm the importance of infarct size in patients undergoing intra-arterial therapy, we sought to characterize the relationship between final infarct volume (FIV) and long-term functional outcome in a prospective cohort of endovascularly treated patients. […]